Major investments into drug development will accelerate demand for inbred and transgenic animal model offerings in the near future.
Major investments into drug development will accelerate demand for inbred and transgenic animal model offerings in the near future.
Fact.MR, Rockville MD: A new report on the animal model market by market research company Fact.MR has projected positive growth prospects for 2021. The covid-19 pandemic had generated potential opportunities for growth in terms of vaccine development efforts, which are expected to positively affect the industry in the long term. Moreover, the market is expected to display steady growth through 2021, with the relaxation of social distancing regulations, impacting research endeavors.
According to the National Library of Medicine, animal models which are used to mimic human ailments, are proving to be key tools invaluable for improved understanding for disease pathogenesis and associated treatment strategies. In recent years, the use of mouse models for RRV-induced diseases has aided researchers in studying the pathobiology of infection and novel drugs to relieve disease symptoms.
RRV has gained popularity as an infection model with the potential for deriving key insights in major disease processes, particularly a number of alphaviruses, are known for their roles in infectious disease. Research into the development of non-human primate animal models has generated insights into the varied aspects of tropism and pathogenesis, thereby facilitating research and development of novel treatment strategies.
“Increased demand for animal testing for vaccine safety checks for ailments such as malaria and tuberculosis are driving demand for animal models. Further, increased interest in personalized medicine and targeted therapeutics for cancer treatments has also bolstered production and quality control in the in international research centers,” comments a Fact.MR analyst.
Request a report sample to gain detailed insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=1590
Key Takeaways from Fact.MR’s Animal Model Market
- Growing application of CRISPR in biomedical research in developed countries is emerging as a prominent influencer for market development.
- Personalized medicine research applications will play a key role in sales and adoption of animal models.
- Mice models will remain highly popular, supported by higher levels of physiological similarities compared to humans.
- UK will reflect a surge in the adoption of animal models, supported by novel vaccine development applications.
- Japan has emerged as a leading regional market in Asia driven by investments into regenerative medicine research.
- Preclinical activity and biomedical research supports growth in the United States through the coming decade.
Animal Model Market – Prominent Drivers
- Integration of bioinformatics with in vitro cell cultures reduce animal requirements and support the rise of the market.
- Advances in alternative 3D modelling and artificial intelligence for biomimetic systems and microfluidic channels will sustain growth.
- Innovations aimed towards biotechnology research, and faster access to new drugs will support long-term growth.
Animal Model Market – Key Restraints
- Inconsistencies in the physiology between animal and human bodies are key factors that will hinder use in drug and vaccine development.
- Ethical and regulatory constraints associated with animal testing practices are restricting adoption rates.
Discover more about the animal model market with figures data tables and table of contents. You can also find detailed market segmentation at https://www.factmr.com/report/1590/animal-model-market
Competitive Landscape
Major players in the animal model market include but are not limited to Transposagen Biopharmaceuticals, Inc., Genoway SA, Envigo CRS SA, Eurofins Scientific SE, and Crown Bioscience Inc.
Leading players in the animal model market are reflecting interest in research and development endeavors with funding efforts to translatability in drug development efforts. For instance, in March 2021, Melior Discovery revealed research efforts aimed towards an acne model for sebum production and phenotype screening for drug repositioning and translatability.
Manufacturers are also pushing for research applications including clinical trials to consolidate their market positions. For instance, Nova Mentis announced the expansion of its preclinical pipeline for testing psychedelic treatments known as PLZ-1013 for fragile X syndrome animal model.
More Insights on the Animal model Market
In its latest report, Fact.MR offers unbiased analysis of the global animal model market. In order to comprehend the global market potential, its growth, and scope, the market is segmented on the basis of species (rats, mice, guinea pig, rabbits, monkeys, dogs, pigs, cats, and others), application (basic and applied research, and drug discovery/development) and end user (academic & research institutes, pharmaceutical companies, biotechnology companies, contract research organizations, and others) across six regions (North America, Latin America, Europe, South Korea, Asia Pacific, and Middle East & Africa)
Request more information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=1590
Explore Fact.MR’s Coverage on the Healthcare Domain
Fluid Management Market: A recent study by Fact.MR on the fluid management market offers a 5-year forecast for 2020 to 2025. The study analyzes key trends that are currently influencing the growth of the market. This report covers vital dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.
Viscoelastic Agents Market: Fact.MR’s extensive coverage on the viscoelastic agents market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the landscape.
Breathalyzer Market: The global breathalyzer market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Sudip Saha
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Source: Fact.MR